Tokio Marine Asset Management Co. Ltd. Purchases 5,741 Shares of Kenvue Inc. (NYSE:KVUE)

Tokio Marine Asset Management Co. Ltd. raised its position in Kenvue Inc. (NYSE:KVUE) by 11.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 54,550 shares of the company’s stock after purchasing an additional 5,741 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Kenvue were worth $1,262,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Lorne Steinberg Wealth Management Inc. increased its holdings in Kenvue by 59.0% in the second quarter. Lorne Steinberg Wealth Management Inc. now owns 154,690 shares of the company’s stock valued at $2,812,000 after purchasing an additional 57,375 shares during the period. Kennon Green & Company LLC raised its position in shares of Kenvue by 140.7% during the second quarter. Kennon Green & Company LLC now owns 159,106 shares of the company’s stock worth $2,893,000 after acquiring an additional 93,008 shares during the last quarter. Czech National Bank lifted its stake in shares of Kenvue by 20.3% in the second quarter. Czech National Bank now owns 364,886 shares of the company’s stock worth $6,634,000 after acquiring an additional 61,635 shares during the period. Crestwood Advisors Group LLC boosted its holdings in Kenvue by 14.8% in the second quarter. Crestwood Advisors Group LLC now owns 1,537,348 shares of the company’s stock valued at $27,950,000 after acquiring an additional 198,607 shares during the last quarter. Finally, Clearbridge Investments LLC boosted its holdings in Kenvue by 16,051.1% in the first quarter. Clearbridge Investments LLC now owns 9,813,597 shares of the company’s stock valued at $210,600,000 after acquiring an additional 9,752,836 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. Jefferies Financial Group began coverage on shares of Kenvue in a report on Tuesday, September 24th. They set a “buy” rating and a $27.00 price target for the company. JPMorgan Chase & Co. lifted their target price on shares of Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Deutsche Bank Aktiengesellschaft increased their price target on Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Royal Bank of Canada lowered Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 target price for the company. in a research report on Tuesday, September 24th. Finally, Bank of America boosted their price objective on Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. According to MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus price target of $22.64.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $23.84 on Friday. The company has a market capitalization of $45.70 billion, a P/E ratio of 43.34, a price-to-earnings-growth ratio of 2.10 and a beta of 1.36. The company’s 50-day moving average is $22.75 and its 200 day moving average is $20.65. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.13.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. The firm had revenue of $3.90 billion for the quarter, compared to analysts’ expectations of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the company earned $0.31 earnings per share. On average, equities research analysts forecast that Kenvue Inc. will post 1.07 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be paid a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 annualized dividend and a dividend yield of 3.44%. Kenvue’s payout ratio is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.